期刊文献+

他汀类药物对血糖的影响 被引量:1

Effect of Statins on Blood Glucose
下载PDF
导出
摘要 随着他汀类药物应用的增多,人们发现其对人体血糖可能产牛影响。一些大的临床研究中关于他汀对血糖的影响结果并不一致;相关的Meta分析中,有的表明他汀类药物可增加新发糖尿病的风险。他汀类药物可能通过减少甲羟戊酸的合成及作用于细胞表面的葡萄糖转运蛋白,影响胰岛素的分泌,进而影响血糖水平及糖耐量。 With the use of statins its effect on blood glucose is find out. Some results of research about it are not same. Some of the Mcta analysis about this show that statins can increase the danger of new - onset diabetes mellitus. Through decreasing the synthesis of mevalonic acid and effecting on the GLUT of cell surface, statins may effect secretion of insulin. Blood glucose and sugar tolerance are also effected.
出处 《国际老年医学杂志》 2013年第6期277-280,共4页 International Journal of Geriatrics
关键词 他汀 血糖 糖尿病 胰岛素 糖化血红蛋白 Statins Blood glucose Diabetes mellitus Insulin Glycosylated hemoglobin
  • 相关文献

参考文献19

  • 1Freeman DJ, NorrieJ, Sattar N, et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study[J]. Circulation, 2001, 103 (3): 357 - 362.
  • 2Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with sirnv?astatin in 20, 536high - risk individuals: a randomised placebo - controlled trial[J]. Lancet, 2002, 360 (9326): 7 -22.
  • 3Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hyperten?sive patients who have average or lower - than - average cholesterol concentrations, in the Anglo - Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT - LLA): a multieentre randomised controlled trial[J]. Lancet, 2003, 361 (9364): 1149-1158.
  • 4Ridker PM, Danielson E, Fonseca FA, et u. t{",uv?astatin to prevent vascular events in men and women with elevated C - reactiveprotein[J]. N EnglJ Med, 2008, 359 (21): 2195 - 2207.
  • 5Culver AL, Ockene IS, Balasubramanian R, et al. Starin use and risk of diabetes mellitus in postmenopa?usal women in the women' s health initiative[J] . Arch Intern Med, 2012, 172 (2): 144 -152.
  • 6Sattur N, Preiss D, Murray H M, et a1. Statins and risk of incident diabetes: a collaborative meta - analy?sis olrandomised statin trials l.l]. Lancet , 2010, 375 (9716): 735 -742.
  • 7Rajpathak SN, Kurnbhani Dol, Crandall .I, et a1. Sta?tin therapy and risk of developing type 2 diabetes: a meta - analysis l.lJ. Diabetes Care, 2009, 32 (10): 1924 - 1929.
  • 8杨倩,崔炜,都军.长期应用他汀类药物与新发糖尿病关系的Meta分析[J].临床荟萃,2010,25(3):237-241. 被引量:4
  • 9Preiss D, Seshusai SR, Welsh P, et a1. Risk of inci?dent diabetes with inte-nsive - dose compared with mod?crate - dose statin therapy: a meta - analysis[J].JA?MA, 2011, 305 (24): 2556 -2564.
  • 10Nakata M, Nagasaka S, Kusaka I, et a1. Effects of stat ins on the udipocyte maturation and expression of !,:lucosetransp0l1er 4 (SLC2A4): implications in !,:ly?c-ue-mic- control lJ J. Diabetologia , 2006, 49 (8): 1881 - 1892.

二级参考文献23

  • 1Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo controlled trial[J]. Lancet, 2002,360 (9326) : 7-22.
  • 2Sasaki J, Iwashita M, Kono S. Statins: beneficial or adverse for glucose metabolism[J]. J Atheroscler Thromb, 2006, 13( 3 ):123-129.
  • 3Rizzo M,Spinas GA,Rini GB,et al. Is diabetes the cost to pay for a greater cardiovascular prevention[J]. Int J Cardiol,2009.
  • 4Alegret M, Silvestre JS. Pleiotropic effects of statins and related pharmacological experimental approaches[J]. Methods Find Exp Clin Pharmacol,2006,28(9):627-656.
  • 5Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)[J]. Lancet, 1994,344(8934) : 1383-1389.
  • 6Shepherd J,Cobbe SM, Ford I, et al. For the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypereholesterolemia[J]. N Engl J Med, 1995, 333 (20): 1301-1307.
  • 7Sacks FM, Pfeffer MA, Moye I.A, et al. For the Cholesterol and Recurrent Events Trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J]. N Engl J Med, 1996,335(14) :1001-1009.
  • 8The Long-term Intervention with Pravastatin in lschemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J]. N Engl J Med,1998,339(19) :1349-1357.
  • 9Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS[J]. JAMA,1998,279(20) :1615-1622.
  • 10Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia[J]. Lancet,2000,356(9242) : 1627-1631.

共引文献3

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部